Back to Search
Start Over
'Cost-effectiveness of the three EMA-approved adjuvant systemic therapies in patients with high-risk melanoma: a model-based economic evaluation'.
- Source :
- European Journal of Surgical Oncology; Feb2022, Vol. 48 Issue 2, pe50-e50, 1p
- Publication Year :
- 2022
- Subjects :
- COST effectiveness
MELANOMA
PATIENTS
Subjects
Details
- Language :
- English
- ISSN :
- 07487983
- Volume :
- 48
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- European Journal of Surgical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 155399668
- Full Text :
- https://doi.org/10.1016/j.ejso.2021.12.412